Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Oral vancomycin safely induced and maintained remission of ulcerative colitis among a subset of ...
September 15, 2010 (Boston, Massachusetts) — Fidaxomicin is superior to vancomycin in treating recurrences of gastrointestinal Clostridium difficile infection, according to a blinded randomized trial ...
The use of oral vancomycin prophylaxis was associated with a significant decrease in the recurrence of Clostridium difficile infection, according to a poster presentation at the Interscience ...
Amneal is voluntarily recalling four lots of Vancomycin Hydrochloride for Oral Solution, 250 mg/5 mL packaged in 80 mL, 150 mL or 300 mL pack sizes, to the consumer level. Some bottles may have been ...
Vancomycin is indicated to treat enterocolitis caused by Staphylococcus aureus and antibiotic-associated pseudomembranous colitis caused by C. difficile. ANI Pharmaceuticals announced that the Food ...
BAUDETTE, Minn., Sept. 11, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the launch of Vancomycin HCl for Oral Solution, 250mg per 5mL (the generic equivalent ...
A new study presented at the 53rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy meeting in Denver by researchers at Montefiore Medical Center and Albert Einstein College of ...
September 23, 2011 (Chicago, Illinois) — Oral vancomycin and oral metronidazole appear to be equally effective in treating patients with Clostridium difficile infection, regardless of the severity of ...
Background: The association between the use of proton pump inhibitors and the risk of Clostridium difficile-associated disease (CDAD) is controversial. In this study we re-examined a previously ...
During the manual bottle filling stage of manufacturing, some bottles may have been overfilled resulting in an over potent dosing regimen. Amneal Pharmaceuticals, LLC is voluntarily recalling 4 lots ...
The FDA on Monday granted approval to CutisPharma’s drug Firvanq to treat Clostridium difficile-associated diarrhea and Staphylococcus aureus-associated intestinal inflammation (enterocolitis). Here ...